KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Long-Term Deferred Tax (2016 - 2026)

Staar Surgical (STAA) has disclosed Long-Term Deferred Tax for 16 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Deferred Tax fell 62.87% year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Sep 2025, down 62.87%, and an annual FY2024 reading of $788000.0, down 84.82% over the prior year.
  • Long-Term Deferred Tax was $2.0 million for Q3 2025 at Staar Surgical, down from $11.9 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $11.9 million in Q2 2025 and bottomed at $788000.0 in Q4 2024.
  • Average Long-Term Deferred Tax over 5 years is $4.9 million, with a median of $4.6 million recorded in 2021.
  • The sharpest move saw Long-Term Deferred Tax plummeted 84.82% in 2024, then soared 134.21% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $3.8 million in 2021, then surged by 129.32% to $8.7 million in 2022, then crashed by 40.65% to $5.2 million in 2023, then tumbled by 84.82% to $788000.0 in 2024, then soared by 150.89% to $2.0 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for STAA at $2.0 million in Q3 2025, $11.9 million in Q2 2025, and $4.0 million in Q1 2025.